Clinical trial

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

NCT00538629

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-10-16

PhaseN/A

Study timeline

Study start (actual)2007-10-16Date precision: day

Registry last updated2022-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bipolar Disorderunresolved

Schizophreniaunresolved

Interventions

no interventionOTHER

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00538629 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.